← WEST PHARMACEUTICAL SERVICES INC WST
Market Price
$349.15
Market Cap
$24.46B
P/E Ratio
51.42
Revenue (FY 2025)
↑6.3% YoY
$3.07B
3-Yr CAGR: 2.1%
Net Income
↑0.2% YoY
$493.70M
Net Margin: 16.1%
Free Cash Flow
↑69.6% YoY
$468.90M
FCF Yield: 1.92%
EPS (Diluted)
↑1.5% YoY
$6.79
Basic: $6.83
Return on Equity
Efficiency
15.5%
ROA: 25.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (WST)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $1,509.1M | — | $501.1M | $143.6M | — | $1.91 | — | $219.4M | $49.2M | — |
| FY 2017 | $1,599.1M | +6.0% | $512.6M | $150.7M | +4.9% | $1.99 | +4.2% | $263.3M | $132.5M | +169.3% |
| FY 2018 | $1,717.4M | +7.4% | $545.4M | $206.9M | +37.3% | $2.74 | +37.7% | $288.6M | $183.9M | +38.8% |
| FY 2019 | $1,839.9M | +7.1% | $605.7M | $241.7M | +16.8% | $3.21 | +17.2% | $367.2M | $240.8M | +30.9% |
| FY 2020 | $2,146.9M | +16.7% | $767.8M | $346.2M | +43.2% | $4.57 | +42.4% | $472.5M | $298.1M | +23.8% |
| FY 2021 | $2,831.6M | +31.9% | $1,175.8M | $661.8M | +91.2% | $8.67 | +89.7% | $584.0M | $330.6M | +10.9% |
| FY 2022 | $2,886.9M | +2.0% | $1,136.2M | $585.9M | -11.5% | $7.73 | -10.8% | $724.0M | $439.4M | +32.9% |
| FY 2023 | $2,949.8M | +2.2% | $1,129.2M | $593.4M | +1.3% | $7.88 | +1.9% | $776.5M | $414.5M | -5.7% |
| FY 2024 | $2,893.2M | -1.9% | $998.5M | $492.7M | -17.0% | $6.69 | -15.1% | $653.4M | $276.4M | -33.3% |
| FY 2025 | $3,074.1M | +6.3% | $1,104.0M | $493.7M | +0.2% | $6.79 | +1.5% | $754.8M | $468.9M | +69.6% |
Valuation
Market Price
$349.15
Market Cap
$24.46B
Enterprise Value
$23.87B
P/E Ratio
51.42
P/B Ratio
7.77
FCF Yield
1.92%
Dividend Yield
0.25%
Shares Outstanding
Profitability & Margins
Gross Margin
35.91%
Operating Margin
19.03%
Net Margin
16.06%
Return on Equity (ROE)
15.54%
Return on Assets (ROA)
24.96%
Asset Turnover
1.55x
Revenue 3-Yr CAGR
2.12%
Financial Health & Liquidity
Current Ratio
3.02
Cash Ratio
1.21
Debt / Equity
0.064
Debt / Assets
0.103
Cash & Equivalents
$791.30M
Total Debt
$202.80M
Book Value / Share
$44.96
Cash Flow Efficiency
Operating Cash Flow
$754.80M
Capital Expenditures (CapEx)
$285.90M
Free Cash Flow
$468.90M
OCF / Revenue
24.55%
FCF / Revenue
15.25%
FCF 3-Yr CAGR
2.19%
Per Share Metrics
EPS (Diluted)
$6.79
EPS (Basic)
$6.83
Dividends / Share
$0.86
Book Value / Share
$44.96
EPS YoY Growth
1.49%
Balance Sheet (FY 2025)
Total Assets
$1.98B
Total Liabilities
$654.90M
Stockholders' Equity
$3.18B
Current Assets
$1.98B
Current Liabilities
$654.90M